AVITA Medical reported Q2 losses of $(0.41) per share, missing the analyst consensus estimate of $(0.32) by 28.12 percent. This is a 64 percent decrease over losses from the same period last year. However, the company reported quarterly sales of $11.75 million, beating the analyst consensus estimate of $11.32 million by 3.83 percent, a 41.01 percent increase over sales from the same period last year.